08.29.18 to 08.31.18
Minsk, Belarus
National Academy of Sciences building, Washington, D.C.

For the 11th year in a row, the Sabin Vaccine Institute has received Charity Navigator's highest rating.

Dr. Albert Bruce Sabin, best known as the developer of the oral live virus polio vaccine, died 25 years ago. Over the course of a career that spanned nearly six decades, his discoveries and approaches to research shaped the modern world.

Health officials and local researchers have launched an emergency vaccination campaign to stem an outbreak of ceftriaxone-resistant typhoid in Hyderabad, Pakistan. The outbreak has sickened more than 800 people since it began in late 2016.

Sabin to tackle pandemic flu

WASHINGTON, D.C. – January 8, 2018 – The Sabin Vaccine Institute, a non-profit global health organization dedicated to enabling vaccine innovation, making vaccines more accessible and expanding immunization across the globe, is pleased to announce a new three-year $6.6 million grant to help speed the development of next generation influenza vaccines and support related immunization issues. This work is generously supported by the Page Family Donor Advised Fund.

First typhoid conjugate vaccine achieves WHO prequalification, a key step in protecting children and reducing the burden of typhoid

Geneva, Switzerland – January 3, 2018 – A typhoid conjugate vaccine has been prequalified by the World Health Organization (WHO), bringing the vaccine one step closer to reaching millions more people at risk of typhoid.

In November, the Sabin Vaccine Institute convened 28 Latin American journalists for a three-day workshop to share the latest information on vaccines, vaccine safety and related global health issues.

How can we better foster life-long immunization practices, particularly in adolescence?